SOCIETY SESSION: BDA. NEW ONCOLOGY DRUGS – APPROVAL PROCESS AND REIMBURSEMENT SYSTEMS IN EUROPE

Health technology assessments in Europe – are there activities towards harmonization?

F. Meyer